DOCMF (Dr. Martens) YoY EPS Growth: 28.57% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DOCMF Dr. Martens PLC DOCMF
55 GF Score
Price $0.98
GF Value $0.97
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens YoY EPS Growth?

Dr. Martens DOCMF -0.04% 55 YoY EPS Growth is 28.57% as of Mar. 2026. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Dr. Martens's YoY EPS Growth for the quarter that ended in Mar. 2026 was 28.57%.

Dr. Martens's Earnings per Share (Diluted) for the six months ended in Mar. 2026 was $0.05.

Dr. Martens YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Dr. Martens's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens YoY EPS Growth Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only 385.71 -34.03 -43.31 -93.26 433.33

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.27 -220.83 -46.15 51.72 28.57
DOCMF
55GF Score
Dr. Martens PLC DOCMF
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Dr. Martens's YoY EPS Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EPS Growth (A: Mar. 2026 )
=(Earnings per Share (Diluted) (A: Mar. 2026 )-Earnings per Share (Diluted) (A: Mar. 2025 ))/ | Earnings per Share (Diluted) (A: Mar. 2025 ) |
=(0.032-0.006)/ | 0.006 |
=433.33 %

Dr. Martens's YoY EPS Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EPS Growth (Q: Mar. 2026 )
=(Earnings per Share (Diluted) (Q: Mar. 2026 )-Earnings per Share (Diluted) (Q: Mar. 2025 )) / | Earnings per Share (Diluted) (Q: Mar. 2025 )) |
=(0.045-0.035)/ | 0.035 |
=28.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 28.57% mean?
Dr. Martens (DOCMF) has a YoY EPS Growth of 28.57% as of Mar. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Dr. Martens and its competitors.
Is Dr. Martens' YoY EPS Growth too high?
Dr. Martens' current YoY EPS Growth is 28.57%. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' YoY EPS Growth compare to NKE and DECK?
Dr. Martens' YoY EPS Growth of 28.57% can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Manufacturing - Apparel & Accessories company?
A good YoY EPS Growth depends on the Manufacturing - Apparel & Accessories industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Dr. Martens and its competitors. Dr. Martens's current YoY EPS Growth is 28.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.98 — trading 1.3% above its estimated fair value. The current YoY EPS Growth is 28.57%. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current YoY EPS Growth is 28.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (DOCMF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued. The current stock price of $0.98 is trading 1.3% above its estimated GF Value™ of $0.97. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for DOCMF:

  • YoY EPS Growth: 28.57%
  • GF Value™: $0.97 vs. price of $0.98 (1.3% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score

Get the complete analysis for DOCMF

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.98
Price
$0.97
GF Value